Mario E. Alburges

959 total citations
36 papers, 810 citations indexed

About

Mario E. Alburges is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Mario E. Alburges has authored 36 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cellular and Molecular Neuroscience, 28 papers in Molecular Biology and 2 papers in Neurology. Recurrent topics in Mario E. Alburges's work include Neurotransmitter Receptor Influence on Behavior (27 papers), Receptor Mechanisms and Signaling (26 papers) and Neuropeptides and Animal Physiology (18 papers). Mario E. Alburges is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (27 papers), Receptor Mechanisms and Signaling (26 papers) and Neuropeptides and Animal Physiology (18 papers). Mario E. Alburges collaborates with scholars based in United States, Canada and Venezuela. Mario E. Alburges's co-authors include Glen R. Hanson, James K. Wamsley, Neelam Narang, Paul S. Frankel, Lloyd G. Bush, David E. Moody, Mary Hunt, Robert Parker, John M. Strong and Jessica M. Collins and has published in prestigious journals such as Brain Research, Neuroscience and Journal of Neurochemistry.

In The Last Decade

Mario E. Alburges

36 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario E. Alburges United States 18 536 400 72 63 61 36 810
E. Widerl�v Sweden 11 422 0.8× 272 0.7× 34 0.5× 40 0.6× 42 0.7× 13 698
P. A. Baumann Switzerland 12 429 0.8× 269 0.7× 24 0.3× 59 0.9× 120 2.0× 18 642
J. Bruinvels Netherlands 19 416 0.8× 326 0.8× 36 0.5× 55 0.9× 112 1.8× 54 845
Janet A. Clark United States 14 780 1.5× 623 1.6× 53 0.7× 91 1.4× 57 0.9× 20 1.3k
Abdulghani A. Houdi United States 12 438 0.8× 416 1.0× 96 1.3× 30 0.5× 49 0.8× 21 963
Chyan E. Lau United States 21 622 1.2× 230 0.6× 87 1.2× 60 1.0× 199 3.3× 63 1.1k
C.A. Korduba United States 8 690 1.3× 523 1.3× 23 0.3× 32 0.5× 82 1.3× 24 975
Mary Jeanne Kreek United States 22 868 1.6× 562 1.4× 28 0.4× 43 0.7× 106 1.7× 25 1.2k
T.‐K. Li United States 21 805 1.5× 505 1.3× 60 0.8× 66 1.0× 131 2.1× 29 1.7k
Godfrey Tunnicliff United States 16 409 0.8× 264 0.7× 21 0.3× 22 0.3× 52 0.9× 41 851

Countries citing papers authored by Mario E. Alburges

Since Specialization
Citations

This map shows the geographic impact of Mario E. Alburges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario E. Alburges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario E. Alburges more than expected).

Fields of papers citing papers by Mario E. Alburges

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario E. Alburges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario E. Alburges. The network helps show where Mario E. Alburges may publish in the future.

Co-authorship network of co-authors of Mario E. Alburges

This figure shows the co-authorship network connecting the top 25 collaborators of Mario E. Alburges. A scholar is included among the top collaborators of Mario E. Alburges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario E. Alburges. Mario E. Alburges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanson, Glen R., et al.. (2013). Response of Neurotensin Basal Ganglia Systems during Extinction of Methamphetamine Self-Administration in Rat. Journal of Pharmacology and Experimental Therapeutics. 346(2). 173–181. 16 indexed citations
2.
Alburges, Mario E., et al.. (2011). Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment. Journal of Neurochemistry. 117(3). 470–478. 22 indexed citations
3.
Frankel, Paul S., Amanda J. Hoonakker, Mario E. Alburges, et al.. (2010). Effect of Methamphetamine Self-Administration on Neurotensin Systems of the Basal Ganglia. Journal of Pharmacology and Experimental Therapeutics. 336(3). 809–815. 34 indexed citations
4.
McFadden, Lisa M., Amanda J. Hoonakker, Paula L. Vieira‐Brock, et al.. (2010). Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high‐dose methamphetamine administration. Synapse. 65(8). 771–777. 11 indexed citations
5.
Frankel, Paul S., Mario E. Alburges, Lloyd G. Bush, Glen R. Hanson, & Stephen J. Kish. (2008). Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users. Neuropharmacology. 55(1). 41–46. 51 indexed citations
6.
Alburges, Mario E., Kristen A. Keefe, & Glen R. Hanson. (2001). Unique responses of limbic met-enkephalin systems to low and high doses of methamphetamine. Brain Research. 905(1-2). 120–126. 11 indexed citations
7.
Alburges, Mario E., Brian P. Ramos, Lloyd G. Bush, & Glen R. Hanson. (2000). Responses of the extrapyramidal and limbic substance P systems to ibogaine and cocaine treatments. European Journal of Pharmacology. 390(1-2). 119–126. 17 indexed citations
8.
Alburges, Mario E. & Glen R. Hanson. (1999). Ibogaine pretreatment dramatically enhances the dynorphin response to cocaine. Brain Research. 847(1). 139–142. 8 indexed citations
9.
Alburges, Mario E. & Glen R. Hanson. (1999). Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine. Brain Research. 818(1). 96–104. 16 indexed citations
10.
Hiroi, Noboru, Allen A. Fienberg, Colin N. Haile, et al.. (1999). Neuronal and behavioural abnormalities in striatal function in DARPP‐32‐mutant mice. European Journal of Neuroscience. 11(3). 1114–1118. 58 indexed citations
11.
Alburges, Mario E., et al.. (1996). Lack of long-term changes in cocaine and monoamine concentrations in rat CNS following chronic administration of cocaine. Neurochemistry International. 28(1). 51–57. 5 indexed citations
12.
Alburges, Mario E., et al.. (1993). α2-agonist binding sites in brain: [125I]Para-iodoclonidine versus [3H]para-aminoclonidine. Brain Research Bulletin. 32(2). 97–102. 18 indexed citations
13.
Narang, Neelam, et al.. (1993). Reduction in striatal D2 dopamine receptor mRNA and binding following AF64A lesions. Molecular and Chemical Neuropathology. 20(1). 81–96. 2 indexed citations
14.
Alburges, Mario E., Neelam Narang, & James K. Wamsley. (1993). Alterations in the dopaminergic receptor system after chronic administration of cocaine. Synapse. 14(4). 314–323. 64 indexed citations
15.
Alburges, Mario E., Neelam Narang, & James K. Wamsley. (1993). A sensitive and rapid HPLC‐ECD method for the simultaneous analysis of norepinephrine, dopamine, serotonin and their primary metabolites in brain tissue. Biomedical Chromatography. 7(6). 306–310. 43 indexed citations
16.
Wamsley, James K., et al.. (1993). Characterization of the Binding and Comparison of the Distribution of Benzodiazepine Receptors Labeled with [3H]Diazepam and [3H]Alprazolam. Neuropsychopharmacology. 8(4). 305–314. 6 indexed citations
17.
Narang, Neelam, et al.. (1993). Unilateral Ibotenic Acid Lesion of the Caudate Putamen Results in D2 Receptor Alterations on the Contralateral Side. Experimental Neurology. 121(1). 40–47. 20 indexed citations
18.
Wamsley, James K., Mario E. Alburges, Mary A. Hunt, & David B. Bylund. (1992). Differential localization of α2-adrenergic receptor subtypes in brain. Pharmacology Biochemistry and Behavior. 41(2). 267–273. 50 indexed citations
19.
Alburges, Mario E., et al.. (1991). Fentanyl Receptor Assay. I. Development of a Radioreceptor Assay for Analysis of Fentanyl and Fentanyl Analogs in Urine. Journal of Analytical Toxicology. 15(6). 311–318. 10 indexed citations
20.
Wamsley, James K., William F. Herblin, Mario E. Alburges, & Mary Hunt. (1990). Evidence for the presence of angiotensin II-type 1 receptors in brain. Brain Research Bulletin. 25(3). 397–400. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Widerl�v Breakdown of academic impact, for papers by P. A. Baumann Breakdown of academic impact, for papers by J. Bruinvels Breakdown of academic impact, for papers by Janet A. Clark Breakdown of academic impact, for papers by Abdulghani A. Houdi Breakdown of academic impact, for papers by Chyan E. Lau Breakdown of academic impact, for papers by C.A. Korduba Breakdown of academic impact, for papers by Mary Jeanne Kreek Breakdown of academic impact, for papers by T.‐K. Li Breakdown of academic impact, for papers by Godfrey Tunnicliff
Rankless by CCL
2026